Trans-resveratrol inhibits early blood vessel formation (Vasculogenesis) without impairment of embryonic growth

Journal of Pharmacological Sciences

Volumn 107, Issue 2, 2008, Pages 118-127

  Dias, Paulo Fernando ^a   Berti, Fernanda Vieira ^a   Siqueira Jr , Jarbas Mota ^a   Maraschin, Marcelo ^a   Gagliardi, Antônio Ricardo ^b,c   Ribeiro do Valle, Rosa Maria ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Vascular Surgery Section   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Embryo growth; Stilbene; trans resveratrol; Vasculogenesis and angiogenesis; Yolk sac membrane

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACETYLSALICYLIC ACID; BASIC FIBROBLAST GROWTH FACTOR; INDOMETACIN; PHORBOL DIBUTYRATE; PROTEIN KINASE C; RESVERATROL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EMBRYO; EMBRYO GROWTH; ENZYME INHIBITION; NONHUMAN; VITELLINE MEMBRANE;

EID: 46449121195     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071876     Document Type: Article

References (54)

1. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
2. Carmeliet P. Angiogenesis in health and disease. Nature Med. 2003;9:653-660.
3. Ruiter MC, de Poelmann E, Mentink MMT, Vaniperen L, Gittenberger-de-Groot AC. The early formation of the vascular system in quail embryos. In: Ruiter MC, editor. Development of the vascular system in the embryo. A concept of the origin of systemic-pulmonary collateral arteries. The Netherlands: Leiden Univ Bibl; 1992. p. 99-186.
4. Asahara T, Isner JM. Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res. 2002;11:171-178.
5. Risau W, Sariola H, Zerves HG, Sasse J, Ekblom P, Kemler R, et al. Vasculogenesis and angiogenesis in embryonic-stem-cell derived embryoid bodies. Development. 1988;102:471-478.
6. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
7. Mundel T, Kalluri R. Type IV collagen-derived angiogenesis inhibitors. Microvasc Res. 2007;74:85-89.
8. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
9. Bergers G, Benjamin LE. Tumorigenesis and the angiogenesis switch. Nature Rev Cancer. 2003;3:401-410.
10. Ribatti D, Vacca A, Nico B, Roncali L, Dammacco F. Postnatal vasculogenesis. Mech Develop. 2001;10:157-163.
11. Zammaretti P, Zisch AH. Adult endothelial progenitor cells renewing vasculature. Int J Biochem Cell Biol. 2005;37:493-503.
12. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
13. Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol. 2003;65:173-179.
14. Tan W, Lin L, Li M, Zhang YX, Tong Y, Xiao D, et al. Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol. 2003;459:255-262.
15. Oak M-H, El Bedoui J, Schini-Kertha VB. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem. 2005;16:1-8.
16. Frémont L. Biological effects of resveratrol. Life Sci. 2000;66:663-673.
17. Stervbo U, Vang O, Bonnesen C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem. 2007;101:449-457.
18. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem. 1997;30:91-113.
19. Formica JV, Regelson W. Review of the Biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995;33:1061-1080.
20. Ciolino HP, Daschner PJ, Yeh GC. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res. 1998;58:5707-5712.
21. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem. 2007;294:137-144.
22. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-1526.
23. Gehm BD, McAndrews JM, Chien P-Y, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A. 1997;94:14138-14143.
24. Igura K, Ohta T, Kuroda Y, Kaji K. Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001;171:11-16.
25. Costello L, Tessitore L. Resveratrol inhibits cell cycle progression in U937 cells. Oncol Rep. 2005;13:133-137.
26. Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Proliferat. 2006;39:479-493.
27. Hamburger V, Hamilton H. A series of normal stages in the development of the chick embryo. J Morphol. 1951;88:49-92.
28. Jakob W, Jentzsch KD, Mauersberger B, Heder G. The chick embryo chorioallantoic membrane as a bioassay for angiogenesis factors: reactions induced by carrier materials. Exp Pathol. 1978;15:241-249.
29. Nguyen M, Shing Y, Folkman J. Quantitation of angiogenesis and antiangiogenesis. In the chick embryo chorioallantoic membrane. Microvasc Res. 1994;47:31-40.
30. Dias PF, Siqueira JM, Vendruscolo LF, Neiva TJ, Maraschin M, Gagliardi AR, et al. Antiangiogenic and antitumoral properties of polysaccharide isolated from the seaweed Sargassum stenophyllum. Cancer Chemother Pharmacol. 2005;56:436-446.
31. Chapman SC, Collignon J, Schoenwolf GC, Lumsden A. Improved method for chick whole-embryo culture using a filter paper carrier. Dev Dynam. 2001;220:284-289.
32. Gagliardi AR, Collins DC. Inhibition of angiogenesis by antiestrogens. Cancer Res. 1993;53:533-535.
33. Szende B, Tyihak E, Kiraly-Veghely Z. Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures. Exp Mol Med. 2000;32:88-92.
34. Vu MT, Smith CF, Burger PC, Klintworth GK. An evaluation of methods to quantitate the chick chorioallantoic membrane assay in angiogenesis. Lab Invest. 1985;53:499-508.
35. Park SY, Jeong KJ, Lee J, Yoon DS, Choi WS, Kim YK, et al. Hypoxia enhances LPA-induced HIF-1α and VEGF expression: Their inhibition by resveratrol. Cancer Lett. 2007;258:63-69.
36. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218-220.
37. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, Du Bois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705-716.
38. Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Phys. 1996;169:522-531.
39. Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann N Y Acad Sci. 2000;902:201-207.
40. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55:498-510.
41. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, et al. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol. 1997;53:1649-1657.
42. Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y, Kawata M, et al. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res. 1999;59:4413-4418.
43. Szkudelski T. Resveratrol inhibits insulin secretion from rat pancreatic islets. Eur J Pharmacol. 2006;552:176-181.
44. Subbaramaiah K, Michaluart P, Chung WJ, Tanabe T, Telang N, Dannemberg AJ. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann N Y Acad Sci. 1999;889:214-223.
45. Matsuda H, Kageura T, Morikawa T, Toguchida I, Harima S, Yoshikawa M. Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages. Bioorg Med Chem Lett. 2000;10:323-327.
46. Pendurthi UR, Williams JT, Rao LV. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells: a possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol. 1999;19:419-426.
47. Shibley IA, Pennington SN. Sodium ion-dependent (N-methylamino)-α- isobutyric acid uptake by embryonic chick cells exposed to ethanol in ovo: response to the stimulation/downregulation of protein kinases. Alcohol Alcoholism. 1998;33:451-456.
48. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996;98:2018-2026.
49. Garcia-Garcia J, Micol V, de Godos A, Gomez-Fernandez JC. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. Arch Biochem Biophys. 1999;372:382-388.
50. Cristofanilli M, Charnsangavej C, Ortobagyi, GN. Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov. 2002;1:415-426.
51. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739-752.
52. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000;156:361-381.
53. Gullino PM. Angiogenesis and oncogenesis. J Natl Cancer Inst. 1978;61:639-643.
54. Hlatky L, Folkman F. Clinical application antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst. 2002;94:883-893.